相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anemonin reduces hydrogen peroxide-induced oxidative stress, inflammation and extracellular matrix degradation in nucleus pulposus cells by regulating NOX4/NF-κB signaling pathway
Zhijia Ma et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2023)
Anemonin inhibits sepsis-induced acute kidney injury via mitigating inflammation and oxidative stress
Dan Liu et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2023)
The role of PARP1 in neurodegenerative diseases and aging
Kanmin Mao et al.
FEBS JOURNAL (2022)
Targeting aging mechanisms: pharmacological perspectives
Alexey Moskalev et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2022)
Anti-inflammatory effects of anemonin on acute ulcerative colitis via targeted regulation of protein kinase C-θ
Lu Jiang et al.
CHINESE MEDICINE (2022)
Evolving concepts in NAD+ metabolism
Claudia C. S. Chini et al.
CELL METABOLISM (2021)
Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1
Huanhuan Hou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation
Vivek Singh et al.
INFLAMMATION (2020)
The taming of PARP1 and its impact on NAD plus metabolism
Sarah Hurtado-Bages et al.
MOLECULAR METABOLISM (2020)
SIRT1 and aging related signaling pathways
Cui Chen et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2020)
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases
Lorenzo Cuollo et al.
BIOLOGY-BASEL (2020)
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
Elizaveta E. Alemasova et al.
NUCLEIC ACIDS RESEARCH (2019)
Swiss Target Prediction: updated data and new features for efficient prediction of protein targets of small molecules
Antoine Daina et al.
NUCLEIC ACIDS RESEARCH (2019)
A decade of clinical development of PARP inhibitors in perspective
J. Mateo et al.
ANNALS OF ONCOLOGY (2019)
The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers
Tatiana Kamaletdinova et al.
CELLS (2019)
Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming
Agnes L. C. Ong et al.
AGEING RESEARCH REVIEWS (2018)
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders
Robert J. Henning et al.
CARDIOVASCULAR TOXICOLOGY (2018)
Anti-Aging Drugs - Prospect of Longer Life?
Blanka Klimova et al.
CURRENT MEDICINAL CHEMISTRY (2018)
PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity
Siyuan Zha et al.
STEM CELL RESEARCH & THERAPY (2018)
PARPs in genome stability and signal transduction: implications for cancer therapy
Luca Palazzo et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
Anemonin attenuates osteoarthritis progression through inhibiting the activation of IL-1β/NF-κB pathway
Zuqiang Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
SIRT1 and NAD + precursors: Therapeutic targets in multiple sclerosis a review
Vamshi K. C. Nimmagadda et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Antifungal, molluscicidal and larvicidal assessment of anemonin and Clematis flammula L. extracts against mollusc Galba truncatula, intermediate host of Fasciola hepatica in Tunisia
Rakia Saidi et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2017)
Age-Related Diseases and Clinical and Public Health implications for the 85 Years Old and Over Population
Efraim Jaul et al.
FRONTIERS IN PUBLIC HEALTH (2017)
Sirt1 and Parp1 as epigenome safeguards and microRNAs as SASP-associated signals, in cellular senescence and aging
Seyedhossein Hekmatimoghaddam et al.
AGEING RESEARCH REVIEWS (2017)
Anemonin Alleviates Nerve Injury After Cerebral Ischemia and Reperfusion (I/R) in Rats by Improving Antioxidant Activities and Inhibiting Apoptosis Pathway
Dong Jia et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease
Peter Bai et al.
CELL METABOLISM (2012)
SIRT1 and p53, effect on cancer, senescence and beyond
Jingjie Yi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Inflammatory and age-related pathologies in mice with ectopic expression of human PARP-1
Aswin Mangerich et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
PARP1 ADP-ribosylates lysine residues of the core histone tails
Simon Messner et al.
NUCLEIC ACIDS RESEARCH (2010)
Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function
Simon Messner et al.
FASEB JOURNAL (2009)
Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt
Marcella Fulco et al.
DEVELOPMENTAL CELL (2008)
AMP-activated protein kinase is a positive regulator of poly(ADP-ribose) polymerase
JW Walker et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-κB-dependent transcription
PO Hassa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
分享论文
